ABVX.PA
Price:
$10.48
Market Cap:
$663.02M
ABIVAX Société Anonyme discovers and optimizes drugs for the treatment of inflammatory diseases, infectious diseases, and cancer in France. Its principal products include ABX464 that is in Phase IIb clinical trials for the treatment of ulcerative colitis and Crohn's Disease, as well as for COVID-19; Phase IIa clinical trial for the treatment of rheumatoid arthritis diseases; and has completed Phase IIa clinical trial for the treatment of viral remission in patients with HIV. It also develops ABX 196, an immune enhancer candidate that is in Phase 1/2 clinical trials for the treatment of hepatocellular cancer. In addition, the company engages in the research programs for the treatment of Dengu...[Read more]
Industry
Biotechnology
IPO Date
2015-06-26
Stock Exchange
EURONEXT
Ticker
ABVX.PA
According to ABIVAX Société Anonyme’s latest financial reports and current stock price. The company's current Enterprise Value is 466.54M. This represents a change of 67.51% compared to the average of 278.52M of the last 4 quarters.
The mean historical Enterprise Value of ABIVAX Société Anonyme over the last ten years is 223.55M. The current 466.54M Enterprise Value has changed 20.77% with respect to the historical average. Over the past ten years (40 quarters), ABVX.PA's Enterprise Value was at its highest in in the December 2020 quarter at 496.86M. The Enterprise Value was at its lowest in in the March 2014 quarter at 0.
Average
223.55M
Median
176.59M
Minimum
55.40M
Maximum
496.86M
Discovering the peaks and valleys of ABIVAX Société Anonyme Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 131.53%
Maximum Annual Enterprise Value = 496.86M
Minimum Annual Increase = -66.55%
Minimum Annual Enterprise Value = 55.40M
Year | Enterprise Value | Change |
---|---|---|
2023 | 226.43M | 43.68% |
2022 | 157.60M | -66.55% |
2021 | 471.12M | -5.18% |
2020 | 496.86M | 73.93% |
2019 | 285.66M | 131.53% |
2018 | 123.38M | 47.65% |
2017 | 83.56M | 50.84% |
2016 | 55.40M | -60.40% |
2015 | 139.89M | -28.47% |
2014 | 195.58M | 0.75% |
The current Enterprise Value of ABIVAX Société Anonyme (ABVX.PA) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
285.05M
5-year avg
327.53M
10-year avg
223.55M
ABIVAX Société Anonyme’s Enterprise Value is greater than ERYTECH Pharma S.A. (19.44M), greater than GenSight Biologics S.A. (57.93M), greater than Innate Pharma S.A. (135.23M), greater than Poxel S.A. (26.98M), greater than Nanobiotix S.A. (194.16M),
Company | Enterprise Value | Market cap |
---|---|---|
19.44M | $48.66M | |
57.93M | $41.64M | |
135.23M | $165.95M | |
26.98M | $29.32M | |
194.16M | $218.88M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like ABIVAX Société Anonyme using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like ABIVAX Société Anonyme or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Enterprise Value?
How can you use the Enterprise Value?
What is ABIVAX Société Anonyme's Enterprise Value?
What is the highest Enterprise Value for ABIVAX Société Anonyme (ABVX.PA)?
What is the 3-year average Enterprise Value for ABIVAX Société Anonyme (ABVX.PA)?
What is the 5-year average Enterprise Value for ABIVAX Société Anonyme (ABVX.PA)?
How does the current Enterprise Value for ABIVAX Société Anonyme (ABVX.PA) compare to its historical average?